133 results
Page 2 of 7
8-K
eno q0suooqrwh
28 Dec 22
Other Events
8:10am
8-K
EX-99.1
33gnjmajgu4hvs5
14 Nov 22
Acasti Pharma Reports Second Quarter 2023 Operational Results
7:15am
8-K
EX-99.1
rl83c9 4ncdn
30 Sep 22
Acasti Announces Court Dismissal of Stockholder Litigation
4:08pm
8-K
wz8t5ucis2
30 Sep 22
Acasti Announces Court Dismissal of Stockholder Litigation
4:08pm
8-K
EX-99.1
2dfnb7iepwhdo
29 Sep 22
Acasti Announces Voting Results from 2022 Annual and Special Meeting of Shareholders
9:26am
8-K
EX-99.1
9n6rbz lsfx
11 Aug 22
Acasti Pharma Reports First Quarter 2023 Operational Results
7:05am
8-K
EX-99..1
f1hx5
21 Jun 22
Results of Operations and Financial Condition
8:10am
8-K
EX-99.1
3pgllh0748
18 May 22
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, with Intravenous GTX-104 Meeting All Endpoints
7:37am
8-K
EX-99.1
8xntd wros8
25 Mar 22
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
7:36am
8-K
EX-99.1
ttq33cbuc3s txyz
14 Feb 22
Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022
7:10am
8-K
EX-99.1
spuvnh0gt
2 Dec 21
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
7:17am
8-K
EX-99.1
y9ft2xgjofwwq wju
15 Nov 21
Acasti Pharma Announces Annual Stock Option Grants
12:00am
424B5
a0o843el
10 Nov 21
Prospectus supplement for primary offering
7:23am
8-K
EX-99.1
irwx4yq7q67qduv5m
10 Nov 21
Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022
7:09am